In our EOPSP group, two cases had MAPT mutations that have previously been reported in subjects with PSP pathology.18, 19 One EOPSP case had previously described pathogenic NPC1 mutations20 and was therefore excluded from subsequent analyses. The gene discussed is NPC1; the disease is supranuclear palsy, progressive, 1.